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Introduction 
Since  ancient  times,  honey  has  been  used  both  as  a 
food  and  medicine.
1  It  has  been  reported  to  contain 
about  200  substances,
2  mainly  sugars  (95-99%  of 
honey dry matter) and water. Minerals comprise small 
quantities (0.17%) of honey; contain calcium, copper, 
iron,  manganese,  phosphorus  and  potassium  as  the 
most  abundant.  Enzymes  in  honey  composition  are 
mainly  invertase  (saccharase),  diastase  (amylase)  and 
glucose oxidase. Main vitamins that exist in honey are 
Vit C and B group.
3 More than 60 species of bacteria 
including Gram-positives and Gram-negatives, aerobes 
and anaerobes are inhibited by natural honey.
4 It has 
been  shown  that  honey  can  inhibit  the  activation  of 
HIV-1  in  latent  models  of  infection.
5  Also,  honey  at 
various  concentrations  could  inhibit  the  growth  of 
Herpes Simplex Virus-1.
6 Several studies describe anti-
ulcerous  capacity  of  honey.
7,8  As  a  wound  barrier,  it 
has  been  used  to  treat  infections  in  various  types  of 
wounds such as burns, abscesses, diabetic and pressure-
caused ulcers, untreated graft donor sites, and infected 
wounds.
9  Positive  effect  of  honey  as  an 
anticarcinogenic agent was reported in some previous 
studies.
10-12 The anti-inflammatory action of honey was 
seen in the previous reports.
13-15 In addition, antioxidant 
capacity  of  honey  was  previously  reported  by  some 
research groups.
16-19 Clinically, it has been shown that 
natural honey consumption in a defined dose improved 
cardiovascular  risk  factors  and  decreased  total 
cholesterol,  LDL-C,  triacylglycerole,  fasting  blood 
glucose,  C-reactive  protein,  and  increased  HDL-C  in 
overweight  or  obese  people.
20,21  In  animal  models, 
protective effects of chronic oral honey administration 
against ischemia/reperfusion (I/R)-induced arrhythmias 
were  demonstrated.
22  In  another  study,  short  term 
perfusion  of  enriched  Krebs  solution  with  natural 
honey in a state of preconditioning had antiarrhythmic 
activity  in  isolated  rat  heart.
23  More  recently,  we 
showed  that  preischemic  administration  of  honey 
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Purpose: Results of our previous study revealed that preischemic perfusion of honey 
before zero flow global ischemia had cardioprotective effects in rat. The present study 
investigated potential resistance to reperfusion injury following short term postischemic 
administration of natural honey in globally ischemic isolated rat heart. Methods: Male 
Wistar  rats  were  divided  into  five  groups  (n=10-13).  The  rat  hearts  were  isolated, 
mounted on a Langendorff apparatus, allowed to equilibrate for 30 min then subjected to 
30 min global ischemia. In the control group, the hearts were reperfused with drug free 
normal Krebs-Henseleit (K/H) solution before ischemia and during 120 min reperfusion. 
In the treatment groups, reperfusion was initiated with K/H solution containing different 
concentration of honey (0.25, 0.5, 1 and 2%) for 15 min and was resumed until the end 
of 120 min with normal K/H solution. Results: In the control group, VEBs number was 
784±199, while in honey concentration of 0.25, 0.5, 1 and 2%, it decreased to 83±23 
(P<0.001),  138±48  (P<0.01),  142±37  (P<0.001)  and  157±40  (P<0.01),  respectively. 
Number  and  duration  of  VT  and  time  spent  in  reversible  VF  were  also  reduced  by 
honey. In the control group, the infarct size was 54.1±7.8%, however; honey (0.25, 0.5, 
1 and 2%) markedly lowered the value to 12.4±2.4, 12.7±3.3, 11.3±2.6 and 7.9±1.7 
(P<0.001), respectively. Conclusion: Postischemic administration of natural honey in 
global ischemia showed protective effects against ischemia/reperfusion (I/R) injuries in 
isolated  rat  heart.  Antioxidant  and  radical  scavenging  activity,  lipoperoxidation 
inhibition, reduction of necrotized tissue, presence of rich energy sources, various type 
of  vitamins,  minerals  and  enzymes  and  formation  of  NO-contain  metabolites  may 
probably involve in those cardioprotective effects.  
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before zero flow global ischemia had cardioprotective 
effects  in  rat.
24  In  the  present  study,  the  effects  of 
postischemic  perfusion  of  natural  honey  on  global 
myocardial  ischemia/reperfusion  injury  were 
investigated in male rats. 
 
Materials and Methods  
Animals 
Adult  male  Wistar  rats  weighing  270-300  g  were 
supplied  by  the  Laboratory  Animal  Center,  Medical 
Sciences  University  of  Tabriz,  Iran.  The  rats  were 
divided randomly into five groups (n=10-13) and were 
acclimated for at least 1 week at a temperature of 21±3 
◦C and humidity 55±5%. The animals were maintained 
with free access to standard rat food and tap water. The 
experiments  reported  were  carried  out  in  accordance 
with  the  Guide  for  the  Care  and  Use  of  Laboratory 
Animals (National Institutes of Health Publication No 
85-23, revised 1985). 
 
Chemicals 
Honey  (Oskou,  East  Azerbaijan,  Iran), 
Triphenyltetrazolium chloride (TTC, Sigma), Formalin, 
NaCl,  NaHCO3,  KCl,  KH2PO4,  MgSO4,  CaCl2,  D-
glucose (Merck Company), Sodium pentobarbital (Kela 
Company,  Belgium)  and  Heparin  (Daru-pakhsh 
Company, Iran). 
 
Experimental protocols 
To prepare buffer solution for treatment groups, honey 
was  dissolved  in  Krebs-Henseleit  (K/H)  solution  for 
providing its different concentrations (0.25, 0.5, 1 and 
2%).  The  rats  were  anesthetized  by  pentobarbital 
sodium  (50  mg/kg)  and  heparinized  (300  IU)  via 
intraperitoneal  injection.
22  The  rat  hearts  were 
immediately excised and kept in ice cold oxygenated 
K/H solution (pH=7.4), before the aorta was cannulated 
on Langendorff apparatus. After mounting the hearts on 
a  non-recirculating  langendorff  apparatus,  they  were 
perfused under constant pressure of 100 mmHg at 37 
°C  and  perfused  with  K/H  solution  that  previously 
equilibrated with 95% O2-5% CO2 .
22,25 A water-filled 
polyvinylchloride  balloon  was  attached  to  a  pressure 
transducer  and  inserted  into  the  left  ventricle  (LV) 
through  an  incision  in  the  left  atrium.
22,25  The  hearts 
were allowed to equilibrate for 30  min (stabilization) 
and then subjected to 30 min no flow global ischemia 
by halting solution perfusion. In the control group, the 
hearts  were  reperfused  with  normal  K/H  solution  for 
120 min immediately after global ischemia. However, 
in the all treated groups, reperfusion was initiated with 
K/H  solution  containing  different  concentration  of 
honey for 15 min and then resumed until the end of 120 
min with drug free normal K/H solution. 
 
Evaluation of arrhythmias and infarct size 
The ECGs were recorded and analyzed according to the 
diagnostic  criteria  advocated  in  the  Lambeth 
conventions
26  for  determining  cardiac  arrhythmias 
including  number  of  ventricular  tachycardia  (VT), 
number  of  total  ventricular  ectopic  beats 
(VEBs=Single+Salvos+VT), duration and incidence of 
VT and ventricular fibrillation (VF) during first 30 min 
of reperfusion.  
To determine the infarct size, at the end of the 120 min 
reperfusion  period,  the  hearts  were  frozen  at  -20  °C 
then the ventricle of the hearts were sliced transversely 
in a plane perpendicular to the apico-basal axis into 2 
mm-thick sections.
25 The slices then incubated by 1 % 
(w/v) TTC solution in phosphate buffer (NaHPO4, 88 
mM; NaH2PO4 1.8 mM, pH= 7.4) for 15 min at 37 °C 
to  dye  the  non-infarcted  region.
25,27  The  tissue  slices 
were  then  fixed  in  10%  formalin  for  24  h  and  then 
placed  between  two  glass  cover  sheets.  The  sheets 
cause  that  the  tissue  color  can  clearly  be  seen  also 
makes a convenient flat surface for directly tracing the 
dimensions of the infarct and risk zone on a transparent 
sheet.  The  slices  were  drawn  onto  transparent  sheets 
then by using a computerized planimetry package, the 
percentage  of  infarcted  tissue  within  the  volume  of 
myocardium at risk was calculated.
25,27 
 
Statistics analysis 
Data  was  expressed  as  Means±SEM  except  for  the 
incidence  of  VT  and  VF  which  were  indicated  as 
percentage.  Differences  in  the  incidences  of 
arrhythmias were analyzed by using Fisher’s exact test 
(with  Yates  correction).  The  group  means  were 
compared  by  non-parametric  Mann–Whitney  U-test. 
The  infarct  size  was  analyzed  by  one  way  ANOVA. 
Post-hoc  comparisons  were  done  using  LSD. 
Differences were considered as significant for P<0.05. 
 
Results 
The effects of different concentrations of natural honey 
on I/R-induced injuries are summarized in Tables 1-3. 
As shown in Table 1 and Figure 1, perfusion of K/H 
solution containing honey for 15 min in the initiation of 
reperfusion  significantly  decreased  the  number  of 
single  ectopic  beats  by  all  used  concentrations.  The 
number  of  salvos  arrhythmias  was  reduced  from 
221±100 in the control rats to 8±4, 10±4, 14±4 and 4±1 
(P<0.01)  by  0.25,  0.5,  1  and  2%  of  honey  solution, 
respectively. In addition, honey markedly lowered the 
total number of VEBs compared to the control group 
(Figure  2).  In  the  control  group,  VEBs  number  was 
784±199, while in honey concentrations of 0.25, 0.5, 1 
and 2%, it was decreased to 83±23 (P<0.001), 138±48 
(P<0.01),  142±37  (P<0.001)  and  157±40  (P<0.01), 
respectively.  The  amount  of  153±55  in  the  control 
group for VT number was changed to 17±9 (P<0.01), 
41±23  (P<0.05),  54±30  (P<0.05),  and  72±44, 
respectively. At the same time and as shown in Figure 
3, duration of VT was also lowered by natural honey 
from the control value (43±21 sec) to 6±5, 7±4, 8±4 
(P<0.05 for all) and 9±5 sec in 0.25, 0.5, 1 and 2% of 
honey,  respectively.  The  time  spent  in  reversible  VF 
showed  no-significant  reduction  by  the  lower  honey  
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concentrations  (0.25,  0.5  and  1%).  Moreover,  there 
were no significant differences for incidences of VT, 
reversible VF, irreversible VF and total VF between the 
treatment and control groups (Table 2). 
In the control group, the percentage of infarct size was 
54.1±7.8, while in honey concentration of 0.25, 0.5, 1 
and 2%, the value was markedly lowered to 12.4±2.4, 
12.7±3.3,  11.3±2.6  and  7.9±1.7  (P<0.001  for  all), 
respectively  (Figure  4).  In  addition,  the  same 
concentrations  of  honey  significantly  reduced  the 
infarcted  volume  from  832±122  mm³  (control)  to 
125±24, 118±32, 104±25 and 66±16 mm³ (P<0.001), 
respectively.  Risk  zone  volume  (area  at  risk)  in  all 
groups  was  similar  and  did  not  show  significant 
differences between groups (Table 3). 
 
Table 1. Effects of honey (0.25, 0.5, 1 and 2 %) on cardiac arrhythmias during 30 min reperfusion in isolated rat hearts. 
Groups 
Single 
number 
Salvos 
number 
VT 
number 
VEBs 
number 
VT duration 
(Sec) 
Rev VF 
duration (Sec) 
Control  409±94  221±100  153±55  784±199  43±21  240±76 
Honey (0.25 %)  57±14**  8±4**  17±9**  83±23***  6±5*  219±98 
Honey (0.5 %)  87±28*  10±4**  41±23*  138±48**  7±4*  218±100 
Honey (1 %)  73±15**  14±4**  54±30*  142±37***  8±4*  155±51 
Honey (2 %)  79±29**  4±1***  72±44  157±40**  9±5  579±239 
Data are represented as Mean±SEM. *P<0.05, **P<0.01, ***P<0.001 versus the control group. VT; ventricular tachycardia, VEBs; 
ventricular ectopic beats (Single+Salvos+VT), Rev VF; reversible ventricular fibrillation. N=10-13 rats in each group. 
 
Table 2. Effects of honey (0.25, 0.5, 1 and 2 %) on the incidence of cardiac arrhythmias during 30 min reperfusion in isolated rat hearts. 
Groups 
VT 
Incidence (%) 
Rev VF 
Incidence (%) 
Irr Rev VF 
Incidence (%) 
Total VF 
Incidence (%) 
Control  66  66  27  93 
Honey (0.25 %)  50  100  0  100 
Honey (0.5 %)  60  100  0  100 
Honey (1 %)  40  90  10  100 
Honey (2 %)  55  100  0  100 
 VT; ventricular tachycardia, Irr Rev VF; Irreversible ventricular fibrillation. N=10-13 rats in each group. 
 
Table 3. Effects of natural honey on myocardial infarction size after 30 min zero flow global ischemia followed by 120 min reperfusion in 
isolated rat hearts. 
Groups  Risk zone vol. (mm)³  Infarcted vol. (mm)³  Infarct size (%) 
Control  1402±99  832±122  54.1±7.8 
Honey (0.25 %)  1028±32  125±24***  12.4±2.4*** 
Honey (0.5 %)  897±22  118±32***  12.7±3.3*** 
Honey (1 %)  874±19  104±25***  11.3±2.6*** 
Honey (2 %)  814±23  66±16***  7.9±1.7*** 
Data are represented as Mean±SEM. ***P<0.001 versus the control group. N=10-13 rats in each group. 
 
Discussion 
In  the  present  study,  potential  protective  effects  of 
postischemic  administration  of  natural  honey  on 
cardiac arrhythmias and infarct size were investigated 
in globally ischemic isolated rat heart. 
The results of this study clearly showed that treatment 
with  natural  honey  reduced  the  total  number  of 
different ectopic beats (single, salvos, VT) and also the 
incidence  and  duration  of  ventricular  arrhythmias 
including  VT  and  VF.  These  effects  are  ultimately 
important, not only because ischemic heart diseases are 
a  leading  cause  of  death,  but  also  using  honey  as  a 
natural nutritional  agent is  a novel  approach.  Present 
results are substantiated by the results of previous work 
showing that long time oral honey administration to rat 
(feeding of rats by different concentrations of honey for 
45 days) could reduce arrhythmias and infarct size after 
I/R.
22 In addition, we showed that short term perfusion 
of  natural  honey  as  a  preconditioning  agent  caused 
antiarrhythmic activity in isolated rat heart.
23   
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Figure 1. Number of single, salvos and VT in the control and treated groups receiving 0.25, 0.5, 1 and 2 % of honey for 15 min at the 
beginning of reperfusion. Data are represented as Mean±SEM. *P<0.05, **P<0.01, ***P<0.001 versus the control group. N=10-13 rats in 
each group. 
 
 
 
 
Figure 2. The total number of ventricular ectopic beats (VEBs) in the control and treated groups receiving 0.25, 0.5, 1 and 2 % of honey 
for 15 min at the beginning of reperfusion. Data are represented as Mean±SEM. **P<0.01, ***P<0.001 versus the control group. N=10-
13 rats in each group. 
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Figure 3. Duration of ventricular tachycardia (VT) in the control and treated groups receiving 0.25, 0.5, 1 and 2 % of honey for 15 min at 
the beginning of reperfusion. Data are represented as Mean±SEM. *P<0.05 versus the control group. N=10-13 rats in each group. 
 
 
Figure 4. Myocardial infarction size in the control and treated groups receiving 0.25, 0.5, 1 and 2 % of honey for 15 min at the beginning 
of 120 min reperfusion. Data are represented as Mean±SEM. ***P<0.001 versus the control group. N=10-13 rats in each group. 
 
In  another  study  at  the  set  of  regional  ischemia, 
pharmacologic postconditioning by using natural honey 
produced similar protective effects against I/R-induced 
arrhythmias.
28  More  recently,  preischemic 
administration of honey for 15 min before 30 min zero 
flow  global  ischemia  had  marked  and  significant 
reduction  in  the  number,  duration  and  incidence  of 
most  arrhythmia  types  after  I/R.
24  Basically,  the 
mechanism of action of honey is not clear completely; 
however, honey contains many trace elements, such as 
copper, zinc, antioxidants,  and unidentified  materials. 
Its content of fructose and glucose and ratio of them 
might  have  an  important  role  in  such  useful 
functions.
20,21 In addition, it seems that the beneficial 
effects of natural honey in heart may in part be relevant 
to  antioxidant  capacity.  When  cells  suffer  from  I/R 
injury,  the  sudden  generation  of  reactive  oxygen 
species  (ROS)  can  dramatically  disrupt  the  balance 
between  ROS  and  antioxidants  in  injured  tissue  and 
cause an increased demand on the antioxidant defense 
system. In such situation, natural antioxidants including 
superoxide dismutase (SOD), catalase and glutathione 
peroxidase  are  depleted  gradually,  accompanied  by 
accumulation  of  ROS.  In  this  dilemma,  natural 
products can play a significant role in neutralizing ROS 
and  increasing  the  activity  of  natural  antioxidants.  
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Honey  has  been  found  to  contain  significant 
antioxidant agents including glucose oxidase, catalase, 
ascorbic  acid,  flavonoids,  phenolic  acids,  carotenoid 
derivatives, organic acids, Maillard reaction products, 
amino  acids  and  proteins.
29  It  has  demonstrated  that 
honey can increase the antioxidant level of body such 
as β-carotene by 3%, vitamin C concentration by 47% 
and glutathione reductase by 7% .
20 Rakha et al. (2008) 
showed  that  natural  wild  honey  may  exert  its 
cardioprotective  and  therapeutic  effects  against 
epinephrine-induced  cardiac  disorders  and  vasomotor 
dysfunction  directly,  via  its  significant  antioxidant 
capacity.
30  A  significant  correlation  between  the 
antioxidant activity, the phenolic content of honey and 
the  inhibition  of  the  lipoprotein  oxidation  of  human 
serum  was  found.
17  Also  in  a  study  of  comparing 
fructose-fed  rats  and  honey-fed  rats,  honey  receiving 
group had  a  higher  plasma  α-tocopherol  level,  and  a 
higher  α-tocopherol/triacylglycerol  ratio,  as  well  as 
lower plasma nitrate levels and lower susceptibility of 
the heart to lipid peroxidation, which can be a leading 
cause of less free radical production and so decreasing 
myocardium  injuries.
31  Many  epidemiological  studies 
have shown that regular flavonoid intake reduced  the 
risk of cardiovascular diseases
32 by protective effects of 
mainly  antithrombotic,  antiischemic,  antioxidant,  and 
vasorelaxant  activity.
33  All  natural  honeys  almost 
contain  flavonoides  (such  as  apigenin,  pinocembrin, 
kaempferol,  quercetin,  galangin,  chrysin  and 
hesperetin).
34-36  It  seems  that  the  mentioned  effects 
could be expected from flavonoids component of honey 
to  reduce  I/R  injuries.  Furthermore,  natural  honey 
contains  nitric  oxide  (NO)  metabolites  which  are 
known indicators for cardiovascular disease risk.
20 By 
increasing  NO  level,  honey  might  have  a  protecting 
role in such conditions. 
As  mentioned  earlier,  natural  honey  contains  various 
kinds of minerals such as calcium, potassium, chlorine, 
sodium, iron, magnesium and zinc.
17,34 Maybe, some of 
these  minerals  may  be  relevant  to  the  antiarrhythmic 
effects of honey. Hypokalemia can result in arrhythmia 
and cardiac arrest in acute myocardial infarction.
37 Zinc 
is  attributed  to  have  an  inhibitory  action  on  the  free 
radical formation in the heart and magnesium inhibits 
the  voltage  dependent  calcium  channels  and  may 
prevent  cardiac  arrhythmias.  Effects  of  sodium  is 
through the function of Na
+/ Ca
2+ exchange and alter 
Ca
2+  level  within  the  cardiac  cells  and  reduce  the 
incidence of ventricular arrhythmias.
30 
Although  all  used  concentrations  of  honey  exerted 
protective effect, however, 0.25% had partially better 
antiarrhythmic  activity  in  this  model  of  study.  This 
finding  is  similar  to  the  result  of  our  previously 
reported  work.
24  On  the  other  hand,  the  existence  of 
high  amount  of  glucose  in  higher  concentrations  of 
honey may change glucose to lactate in ischemic phase 
and result in electrical and contractility disturbances in 
the  heart.
22  In  addition  to  arrhythmias,  the  results  of 
present  study  showed  that  the  infarct  size  (another 
important parameter  to  evaluate the  severity  of  acute 
myocardial infarction) was significantly reduced by all 
used honey concentrations.  As well as antiarrhythmic 
activity, it has shown that short term administration of 
honey as  a  preconditioning  or  postconditioning  agent 
during  30  min  regional  ischemia  produced  anti-
infarction activity in isolated rat heart.
23,28 In consistent 
with  the  above  findings,  in  a  recent  another  study, 
preischemic administration of honey before zero flow 
global ischemia caused potent reduction in infarct size 
in isolated rat heart.
24 All probable mechanism which 
mentioned for antiarrhythmic effects of honey also can 
attribute in reducing infarct size. Perhaps, antioxidant 
activity, scavenging of free radicals and the existence 
of high energy sources in honey composition (such as 
fructose  and  glucose)  may  be  the  most  important 
potential cardioprotective mechanisms of honey. 
  
Conclusion 
By  considering  all  mechanism  of  action  and  our 
findings,  it  may  be  concluded  that  postischemic 
administration  of  natural  honey  after  30  min  global 
ischemia followed by 120 min reperfusion can prevent 
isolated rat hearts against I/R injuries and consequently 
protect  heart  by  antiarrhythmic  activity  and  reducing 
infarction  size.  Antioxidant  and  radical  scavenging 
activity,  lipoperoxidation  inhibition,  presence  of  rich 
energy sources, various type of vitamins, minerals and 
enzymes and formation of NO-contain metabolites may 
probably  involve  in  those  cardioprotective  effects  of 
natural  honey  in  such  conditions.  Future  studies  are 
required to determine the exact protective mechanism 
(s) of honey.  
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